Phocas Financial Corp Portfolio Changes Q2 2026: Strategic Shifts in Banks and Biotech
InsiderSet data reveals Phocas Financial Corp's significant portfolio adjustments during the second quarter of 2026, including notable increases in bank stocks like NYCB and substantial decreases in holdings such as AMRX.
As of June 30th, 2026, Phocas Financial Corp, an investment advisor firm managing significant assets for clients, has finalized its portfolio adjustments for the second quarter. The data indicates a dynamic period with substantial buying and selling activities across various sectors.
Among the most striking changes was the near-doubling of shares held in FLAGSTAR BANK NATIONAL ASSOC (NYCB), which increased by 98.8%. This significant purchase suggests renewed confidence or strategic interest from Phocas Financial Corp in this financial services entity.
Conversely, the firm divested a considerable portion of its holdings in AMNEAL PHARMACEUTICALS INC (AMRX), which experienced an 18.27% decrease in shares and value during Q2. This exit from the healthcare sector pharma stock could indicate a shift in focus or reassessment of its prospects.
Phocas Financial Corp also demonstrated strong buying activity elsewhere, notably acquiring new positions or significantly increasing stakes in several companies:
- MDU RES GROUP INC (MDU), an industrials stock, saw its shares increase by a massive 96.57%.
- ZEVRA THERAPEUTICS INC (ZVRA) experienced an 85.61% jump in holdings, reflecting substantial investment interest despite its small market cap and niche position.
- GREEN BRICK PARTNERS INC (GRBK), a consumer cyclical stock, was added or increased significantly by Phocas Financial Corp during the quarter.
These actions align with the firm's overall strategy as evidenced by other indicators. The total portfolio value stood at $709 million, and while the top five holdings accounted for only 9.69% of the allocation (a relatively low concentration), there were notable shifts within specific sectors.
In particular, Phocas Financial Corp appears to be actively managing its exposure in the financial services sector beyond just NYCB. The firm increased positions in ALERUS FINL CORP (ALRS) and WILEY JOHN & SONS INC (WLY), both seeing a 100% increase in shares held, indicating potential new interest or consolidation efforts.
The data also confirms that Phocas Financial Corp has been proactive in its portfolio management this quarter. The firm sold positions in several other stocks including VISHAY INTERTECHNOLOGY INC (VSH) and others, reflecting a disciplined approach to risk management and capital allocation.